Drug Makers Warned on Marketing Tactics
From Reuters
U.S. officials issued final guidelines warning drug makers that some marketing practices, including gifts or payments to doctors, may run afoul of anti-kickback laws.
Two “suspect” practices identified by the voluntary guidelines are payments from a company to physicians or pharmacists to switch patients to the manufacturer’s drug and payments to doctors to listen to a pitch from a drug company representative.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
